Back to Top
Feladilimab Biosimilar - Research Grade
$710.00 - $19,500.00
Feladilimab Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>95% by SDS-PAGE
Species Reactivity
Human
Target
ICOS
Concentration
5mg/ml
Isotype
Human IgG4 - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH2819
Uniprot
Q9Y6W8
Shipping Conditions
Blue ice
Background
Inducible T-cell co-stimulator (ICOS) is a CD28-family receptor that sustains effector and follicular helper T-cell responses, of interest across immuno-oncology and autoimmune research. This recombinant anti-human ICOS monoclonal is an unconjugated, non-therapeutic analog of feladilimab, supplied for research use only (RUO). Manufactured to in vivo standards with low endotoxin, it is produced in scalable milligram (mg) to gram (g) quantities for bulk and high-throughput laboratories. Applications include functional assays, co-stimulation and T-cell-modulation studies, reproducible controls, and in vivo immune models, with the consistency required for extended, heavy-usage immunology research.
Specificity
Detects human ICOS
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
4 weeks
Write Your Own Review














